Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Stable Ischemic Heart Disease: later-stage trial registry

1 of 1 indexed Stable Ischemic Heart Disease trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Stable Ischemic Heart Disease: 1 US clinical trial tracked, 1 recruiting.

Stable Ischemic Heart Disease is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Yale University, running 1 of these trials.

Enrollment posture brief

Registry condition stable-ischemic-heart-disease

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Stable Ischemic Heart Di (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Stable Ischemic Heart Disease

Stable Ischemic Heart Disease lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Stable Ischemic Heart Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Stable Ischemic Heart Disease is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Top Sponsors

Yale University 1 trials

Named interventions

Most-linked intervention names on Stable Ischemic Heart Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Calcium channel blocker Drug
1 trials
Clinician Discretion Other
1 trials
Beta blocker Drug
1 trials

US sites by state

Facility locations filed on Stable Ischemic Heart Disease trials. A trial with sites in several states counts in each.

Virginia 1 trials
New York 1 trials
North Carolina 1 trials
Massachusetts 1 trials
Illinois 1 trials
Georgia 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Stable Ischemic Heart Disease page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Stable Ischemic Heart Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Yale University sponsors the most Stable Ischemic Heart Disease trials on record, review their full trial history before evaluating a specific study. See Yale University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Stable Ischemic Heart Disease condition card totals 1 registered trials; most-linked intervention Calcium channel blocker; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.